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On Vitamin C Metabolism in Pulmonary Tuberculosis. 
Following on the preparation of pure crystalline 
vitamin C (ascorbic acid) a great deal of work has been done 
in investigating vitamin C metabolism. 
The present investigation is concerned with the state 
of vitamin C metabolism in patients suffering from pulmonary 
tuberculosis. 
This disease being chronic, apart from any specific 
effect which lack of the vitamin might produce, anything 
which affects the general resistance and health of the 
patient is important. Attention has always been directed 
to diet in tuberculosis. Attempts have been made to 
fatten patients by giving large quantities of food, and 
to improve or cure by giving such things as raw red meat, 
cod liver oil and tomato juice. 
If it were shown that the tuberculosis patient required 
increased quantities of ascorbic acid, the giving of many 
of these diets and the good effects they often produce 
would be rationalised. Also such patients could be given 
extra amounts of the vitamin. 
There are many different methods of determining the 
the state of patients in regard to vitamin C. I chose 
the "saturation" test described by Abbasy, Harris, Ray 
and Marrack (1935). This depends upon ascorbic acid 
being a powerful reducing agent. The amount excreted in 
the urine can be measured by its reducing effect on a blue 
dye - Tillman's reagent, 2:6 dichlorphenolindophenol - 
which is decolourised. 
The first step is to find the total daily excretion 
of ascorbic acid. As described an 0.1% solution of dye 
is employed, standardised frequently against a fresh solution 
of ascorbic acid. The urine is collected in two twelve 
hour periods. As ascorbic acid quickly becomes oxidised, 
especially in light, it is preserved by adding enough 
glacial acetic acid to make a 10% solution and keeping in 
dark glass bottles. The urine is placed in a 2 c.cm. 
micro -burette reading to the nearest 0.01 c.cm. If 
clouded the urine has first to be filtered. 0.05 c.cm. 
of dye solution is measured into a pointed centrifuge tube 
and a titration carried out, the end point being reached 
preferably within 1 minute, certainly within 2 minutes. 
A tube containing a small amount of urine is helpful for 
comparison.. When the urine is added the blue colour 
changos to red. The end point is indicated by the 
disappearance of the red colour. Not less than 0.5 c.cm., 
nor more than 2.0 c.cm. of urine should be used. It is 
usual to continue the test for 6 - 7 days and to calculate 
the daily average. 
As determined by this method, the minimum daily amount 
excreted in a person whose vitamin C nutrition is adequate 
is about 13 mgin. (Harris, Abbasy, Yudkin and Kelly, 1936) . 
Typical examples of gross vitamin C deficiency, such 
as scurvy, are found associated with greatly lowered 
excretion of the reduced vitamin in the urine. Giving 
the vitamin in sufficient quantities cures the patient 
clinically and at the same time the urinary output rises 
to normal. (Harris and Ray, 1935). 
There are several objections to this test 
(1) It is not specific for ascorbic acid. Gluthatione, 
cystein, thiosulphate and ergothionine also decolourise 
the dye (van Eekelen, 1936). If a high protein diet-is 
taken the amount of reducing substance in the urine is 
increased due, as Heinemann (1936) has shown, to increased 
excretion of thiosulphate. In peptic ulceration tuberculosis 
and diabetes, and where the patient has a raised temperature, 
these substances, particularly thiosulphate, may be excreted 
in large amounts and give unduly big readings (van Eekelen 
and Heinemann, 1938). 
(2) Aspirin taken during the test period causes a slight 
increase in the reading (Daniels and Everson, 1936, and 
Parsons, 1938). Youmans, Corlette, Frank and Corlette (1937) 
did not find such an increase. 
(3) The pH of the urine affects its ascorbic acid content, 
raising the pH lowering the reading and lowering the pH 
increasing the reading. (Hawley, Frazer, Button and Stephens, 
1936, confirmed by Coombs, 1937) . 
(4) Even with preservation by 10% glacial acetic acid, 
some oxidation of ascorbic acid occurs, 20 -30% loss in 
12 - 15 hours according to Abbasy, Harris, Ray and Marrack, 
(1935) and Harris, Marrack, Ray and Ward (1935). 
(5) Where the urine is highly coloured the end point 
is difficult to determine (Harde, Rothstein and Ratish, 
1935, and Bullowa, Rothstein, Ratish and Harde, 1936). 
The daily average ascorbic acid excretion for 6 days 
having been found the ttsaturationtt test (Abbasy et a1,1935) 
is proceeded with. This is a confirmatory test to find degree 
of saturation of the patientes tissues with vitamin C. 
70 mgm. ascorbic acid per stone of body weight is given daily 
until a response is obtained, as shown by a considerable 
excretion of ascorbic acid in the urine. In a deficient 
patient most of the ascorbic acid is retained and more than 
two daily doses are required to produce a significant rise 
in excretion. The results of the test can be expressed 
either as the number of days taken to produce saturation, 
or the amount of ascorbic acid necessary to produce 
saturation. 
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The advantages of the saturation test are that most 
of the objections to the simple daily average excretion 
test are disposed of. Thus a large increase in the 
ascorbic acid in the urine is due to excretion of 
ascorbic acid, which has been given by mouth, and not 
to gluthatione, etc., and the test is therefore 
particularly valuable in tuberculosis. Similarly 
with errors due to aspirin, and the colour of the 
urine. Also the amount by which the body is deficient 
in ascorbic acid is measured. Harris et al (1935) 
point out that the test dose technique magnifies the 
relatively small difference from normal obtained by 
the average daily excretion test, especially when 
that test gives figures just below normal or in the 
borderline region of about 10 - 15 mgm. per day. 
These test methods seemed most suitable for 
the present investigation. 
Other tests might have been used. 
(1) Cáillary fragility tests, either a positive 
pressure test - Gothlin's (1931) modification of 
the Rumpel -Leide test, or suction or negative 
pressure tests (Cutter and Johnson, 1935). These 
tests, as Gothlin (1937) says, are useful for mass 
observation and where there are no facilities for 
titration of ascorbic acid. 
(2) Measurement of blood or pla ,_,ascorbic 
acid by the method of Emmerie and van Eekelen (1934), 
or that of Farmer and Abt (1935) or Pijoan and 
Kiemperer's (1937) modification. 
The technique of any of these tests is rather 
more difficult in a small laboratory. Also, as 
suggested by Portnoy and Wilkinson (1938), they 
are best combined with an oral saturation test, 
which increases the difficulties. 
(3) The intradermal test suggested by Rotter 
(1937) and modified by Portnoy and Wilkinson (1938). 
The value of this test has not been confirmed 
(Zoccoli and Lombardo, 1938, fetter, 1938 and 
Goldsmith, Gowe and Ogaard, 1938). 
The present investigation is of 35 patients 
suffering from all stages of pulmonary tuberculosis, 
tested by the saturation test of Abbasy et al (1935) 
The dye for the test was supplied in tablet 
form by Roche Products, Ltd., each tablet containing 
an amount of 2 : 6 dichlorphenolindophenol equivalent 
to 1 mgm ascorbic acid, and when added to 100 c.c. 
of distilled water making an 0.01% solution. The 
urine was titrated against 1 c.cm. of this solution, 
made up freshly every second day. Where the urine 
content of ascorbic acid was high, known dilutions 
of the urine were made with distilled water. Where 
the urine content of ascorbic acid was low, it was 
titrated against 0.5 c.cm. dye solution. 
A third of the daily test dose excreted in the 
following 24 hours was taken as indicating saturation. 
As the urine was passed the amount was measured 
by the nurse in the ward and a quarter of the amount 
saved, to which was added sufficient glacial acetic 
acid to make a io% solution. The smaller amount 
of urine was kept in order to economise acid. The 
objection may be raised that the chances of error 
in its measurement are increased, but the nurse 
soon became quite proficient. In the tests on one 
or two of the patients the whole amount was saved. 
The patients were taken in 3 groups. 
(1) 18 on absolute rest and febrile. 
(2) 6 on absolute rest and afebrile. These 
patients were being kept in bed because of active 
disease. 
(3) 11 on full activity - up for 12 hours each 
day, and doing 3 or 4 hours handicraft or gardening. 
Groups 1 and 2 were thus patients with active 
lesionstiand group 3 patients with inactive lesions. 
All patients, except one, ate, before and 
during the test, a mixed diet containing green 
vegetables and a varying amount of fresh fruit. 
The exception was too ill to take solid food during 
the last part of his test. 
Abbasy et al (1935) have shown that in a 
healthy person 25 mgm ascorbic acid daily, keeps 
his ascorbic acid content at such a level that the 
test dose of ascorbic acid will produce saturation 
in 2 days. 
The patients' diet for the 3 weeks previous 
to the test and during the test was investigated 
by asking them to note the amount of fruit and 
vegetables in each of their meals. They all 
co8perated very well. 
It was arranged to compensate for too small 
or too large intake of ascorbic acid previous to 
and during the test. If the diet was estimated 
to contain less than 25 mgm, daily, after the test 
was completed an orange, which contains about 
25 mgm of ascorbic acid (Abbasy et al, 1935), and 
no other fruit, was given daily for 3 weeks. 
The test was then repeated. If the diet was 
estimated to contain more than 25 mgm.ascorbic acid 
daily, and if the patients became saturated in 
2 days, as their normal ascorbic acid content might 
be due to excess in their diet, after 3 weeks on 
1 orange daily, the test was also repeated. 
A second test was not done if a patient took 
more than 25 mgm.ascorbic acid daily and yet did 
not become saturated in 2 days. 
On 3 patients, although according to the above 
criteria the test should have been repeated, for 
various reasons it was not done. 
The complete results are tabulated at the end 
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25.5 ' 4 
Absolute afebrile cases. 
1. Blackwell 


























































Very ill patients' names underlined. In tests showing discrepancies between average 
daily excretion test áñß saturation test, where the average daily excretion is beyond 
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Average diet, in these tables, is taken as 25 mgm. 
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The amount of ascorbic acid excreted daily 
varied considerably from day to day in some patients. 
For example, Hargreaves who excreted 6.4 mgm. one day 
and 59.8 mgmon the following day, and Milner, 
39.5 mgm. and 4.7 mgra, on successive days.l /The results 
are summarised graphically on the two preceeding pages ./l 
Table l summarises the results and Table 2 
analyses them. 
Table 2 - Analysis of Results 
No . of 
cases 
Ord o' Sanaixa 5i 'i dim. 25 mgni A s corbïc ,/ da.y 
Sat .2 
test doses 







Febrile 18 4 14 2 15 
Absolute 
afebril e 6 3 3 3 3 
Ambulant 11 8 3 9 2 
35 15 20 14 20 
Test not repeated on one case saturated on ++ diet 
It will be seen that only 15 patients out of the 
35 tested showed adequate vitamin C nutrition. One 
of these, (Graupman), who ate no fruit was normal on 
repeating the test, and another (I:ilner) who ate a 
large amount of fruit was subnormal on repetition. 
Of the 18 febrile patients, taking the results 
of the tests uncorrected for diet, 3 were normal. 
After the standardised ascorbic acid intake for 3 
weeks, 2 were normal. 
Of the 6 absolute afeb rile patients 3 were normal 
on their ordinary diet. On repeating the test after 
giving the standard ascorbic acid intake to such cases 
as required it, the results were unchanged. 
Of the 11 ambulant patients 8 were normal, 1 more 
becoming normal after having the standard ascorbic 
acid diet. 
An analysis of the more severe degrees of 
ascorbic acid unsaturation, that is where 4 or more 
test doses were required to produce saturation in a 
patient is shown in Table 3. 




25 mgm ascorbic 
acid daily 
Febrile 9 9 
Absolute afebrile 2 1 
Ambulant 1 0 
This shows that the more severe degrees of 
unsaturation are commonest in febrile patients. 
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Of the 7 very ill patients (Ashe, Gilbody, 
Groom, Higgins, Howard, Lancaster and Nuttal - 
names underlined in red in Table 1) only 1 
(Higgins) was saturated within 2 days, and he 
ate very large amountsof fruit. 2 whose diet 
contained less than 25 mgm.ascorbic acid daily, 
did not become normal after the standard diet. 
Table 4 gives an analysis of the patients 
according to their blood sedimentation rate. 
The method used for determining it was a 
modified Cutler, a 40 mm, column of citrated blood 
being used and a reading taken in 1 hour. A 
12 mm column of serum is the upper limit of 
normality by this method. The results are given 
after 3 weeks on the standardised diet, if 
according to the criteria given above that were 
necessary, otherwise on their ordinary diet. 
- 13 - 
Table 4 - Analysis of results according to 







i.e.4 or more 
test doses 
12 7 5 2 0 
15 3 3 0 0 
20 8 4 4 3 
25 6 1 5 0 
30 7 2 5 4 
30 3 0 3 2 
The sedimentation rate was not done on one 
patient - Groom - who was very ill. His B.S.R. 
would certainly have been over 25. 
This table shows that on the whole there is 
a correlation between the blood sedimentation rate 
and the degree of saturation of the patient. The 
greater the B.S.R. the less the saturation. 
3 of the patients tested, Hargreaves, 
Lancaster and Gilbody, were suffering from 
enteritis. Hargreaves was saturated on 25 mgm 
ascorbic acid per day. Lancaster and Gilbody, 
who both ate more than 25 mgm. ascorbic acid daily 
were unsaturated. 
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The analysis of the temperatures and 
sedimentation rates, together with the figures 
for very ill patients, indicates that the greater 
the activity of the disease, the greater the amount 
of ascorbic acid required to produce saturation, or 
the less adequate is such patients' ascorbic acid 
nutrition. 
Conclusion 
As a general conclusion ascorbic acid deficiency 
is common in patients suffering from pulmonary 
tuberculosis. Such deficiency is very frequent in more 
ill patients and not so frequent in more fit patients. 
Marked deficiency is also common in febrile ill patients 
and uncommon in those with healing lesions. 
A comparison of the value of the average daily 
excretion test and the saturation test is made below. 
As mentioned previously the results of the average 
daily excretion test may vary considerably from day 
to day, interfering with its accuracy. 
On the 35 patients a total of 49 tests was 
performed. Iior reasons given previously the 
saturation test is considered more accurate than 
the average daily excretion test, and so where the 
results of the two different tests do not agree, the 
saturation test result is taken as correct. 
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The results of the 2 different tests agreed 
32 times, 18 times where the patient was shown to 
have adequate ascorbic acid by the saturation test, 
and 14 times where the patient was shown to have 
inadequate ascorbic acid by that test. 
In the case of one febrile patient (Hargreaves)1 
after she was put on 25 mgm, ascorbic acid daily and 
the test repeated, she excreted an average of 
51.3 mgm.of reducing substance daily. Clearly the 
test did not give an accurate estimate of her ascorbic 
acid nutrition. She was saturated in 1 day. 
5 times, where adequate ascorbic was indicated 
by the saturation test, the average daily excretion 
test gave too low a reading. where borderline 
normal average daily excretion of 10 - 15 mgm. are 
excluded there was a discrepancy once. The figure 
in the test was 9.9 mgny'day so that it is just 
outside the b orde y1ine. 
12 times, where inadequate ascorbic acid was 
indicated by the saturation test, the average daily 
excretion test gave too high a reading. Again 
excluding borde ine average daily excretions, there 
was a discrepancy in 8 tests. 7 of these tests were 
done on febrile patients. In 5 of these tests on 
febrile patients the average daily excretion figure 
was over 20 mgm. 
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This shows that the average daily excretion 
figures cannot be relied on to give a true picture 
of ascorbic acid nutrition. Certainly in febrile 
patients suffering from pulmonary tuberculosis the 
results obtained by it are, in many cases, much 
too large. Excluding borderline average daily 
excretion figures of 10 - 15 mgm, then in a 
non -febrile patient an excretion greater than 
15 mgm/day almost certainly means the patient is 
having adequate ascorbic acid, and an excretion 
less than 10 mgm/day that the amount of ascorbic 
acid is inadequate. 
The excessively high results given by the 
average daily excretion test in many febrile patients 
are probably due to excretion of gluthatione and 
similar substances as shown by Heinemann (1936) 
and van Eekelen and Heinemann (1938) . 
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Discussion 
The finding that there is an increased need 
of ascorbic acid in activo pulmonary tuberculosis 
is in agreement with that of other observers - 
Schroeder (1935), Hasselbach (1936), Heise and 
Martin (1931), Bullowa et al (1936), Abbasy, Harris 
and Ellman (1937), Jetter and Bumbalo (1938), 
Singir and van Bark (1938), Hurford (1938) and 
Heinemann (1938). 
The greatly increased deficiency found in 
febrile patients and the correspondence with the 
condition of the patient agree with the results 
of Abbasy, Hill and Harris (1936) (using average 
daily excretion method), Heise and Martin (1936) 
(average daily excretion method), Abbasy, Harris 
and Ellman (1937) (saturation test method of 
Abbasy et al, 1935) Heinemann (1938) (van Eekelen's 
(1936) method of finding daily dose of ascorbic 
acid necessary). 
On the other hand many disagree, that fever 
or activity of the disease vary the requirements 
of vitamin C. 
Hurford (1938) (using average daily excretion 
method) in his investigations on 66 patients did 
not find that pyrexia proved a factor, nor that 
there was a constant relation between the extent 
- 18 - 
and activity of the disease and the ascorbic acid 
state. However he did not control his patients 
ascorbic acid intaO and also the average daily 
excretion test gives too high readings in febrile 
patients. 
Singir and van Bark (1938) ( estimating blood 
ascorbic acid values) also found no correlation 
between the type of tuberculosis and blood ascorbic 
acid values. 
Bullowa et al (1936) (using a saturation test 
method) were also unable tc determine any striking 
correlation between the clinical condition of the 
patients and their ascorbic acid excretion. In 
employing the saturation test they gave relatively 
small doses of vitamin - usually 100 -200 mgm, 
sometimes 400 mgm per day and varied these doses 
from day to day, so that it is difficult to estimate 
the value of their results. 
Vaquette (1937) used a saturation test method, 
giving 300 mgm. ascorbic acid per day, and although 
2 controls were saturated with one such dose, that 
his tuberculosis subjects took 3 - 6 is not so 
valuable as it would be if larger test doses had 
been used. 
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The evidence is thus in favour of increased 
dificiency of ascorbic acid in febrile patients, 
suffering from pulmonary tuberculosis , and the 
more active the disease the more ascorbic acid 
is required. 
Although a state of hypovitaminosis is found 
in chronic disease when afebrile, for example, 
rheumatoid arthritis, (Rinehart, Greenberg and 
Baker, 1936 and Abbasy, Harris and Ellman, 1937) 
and Addison's disease (Wilkinson and Ashford, 1936) 
that fever is important is shown by greatly decreased 
ascorbic acid reserves after the temperature has 
been up only a few days. For example in pneumonia, 
(Harde, Rothstein and Ratish, 1935) Abbasy et al, 
(1935) found that, while their patients were having 
a fixed amount of ascorbic acid daily, the onset 
of a feverish cold or influenza or other infection 
resulted in a sudden drop in daily excretion of 
ascorbic acid, and that an increased amount was 
necessary to restore the output to its previous 
level. Bullowa, Rothstein, Ratish and Harde (1936) 
found that saturation often occurred during a drop 
of temperature. Zook and Sharpless (1938) showed 
that periods of artificial fever increased the 
vitamin C requiremants of man. 
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Wright and MacLenathen (1939) have shown that 
the increase requirement is not due to loss of ascorbic 
acid in the sweat, the loss by this means being 
negligible. 
The work of Harde and Benjamin (1934) on 
laboratory animals confirms these findings. They 
found a reduction of ascorbic acid in tissue in many 
infections and intoxications. 
Harris, Passmore and Pagel (1936) agree. They 
estimated the ascorbic acid content of suprarenals 
and livers of guinea pigs suffering from experimentally 
produced P. pseudo -tuberculosis, B aertryeke infection 
and chronic tuberculosis, etc., and from the effects 
of diphtheria toxin, concluding that "Infection 
causes disappearance of considerable proportion 
of reserves, whether these be high or low." 
The possible explanations of the increased 
vitamin C necessary in patients suffering from 
pulmonary tuberculosis are: - 
(1) Due to the increased temperature, where with 
the increased metabolism more vitamin is required, 
just as more iron, parathyroid hormone etc., are 
required. 
Confirming this are the results set out above, 
Also (a) The increased amounts of ascorbic acid 
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necessary in hyperthyroidism (Sure and Theis, 1938). 
Lewis (1938) found that of 5 hyperthyroid patients, 
who before operation showed less than normal excretion 
of ascorbic acid, 4 had normal excretion after 
operation. 
(b) Exercise increases the requirements of 
rats (van Eekelen and Koay, 1933). 
Even in cases without a temperature a mild 
increased metabolism is a probable factor. 
(2) Due to lack of absorption in the gut. Only 
3 of the series of patients had enteritis and one 
of these (Hargreaves) had persistent diarrhoea, and 
very frequent attacks of vomiting due to partial 
obstruction due to tuberculous peritonitis, yet she 
was saturated in one day. 
Chinn and Farmer (1939) showed increased faecal 
excretion in patients with various gastro- intestinal 
disorders. They specify an alcoholic patient with 
a gastric resection and cases of colitis. Apparently 
no patients suffering from enteritis were tested. 
In view of the frequency of tuberculosis of the 
intestine and general mild gastro- intestinal upset, 
lack of absorption cannot be excluded. 
Wright and Lilienfeld ( 1936) suggest that 
anacidity or imbalance of the gastric excretion, 
bacterial destruction of vitamins in the upper part 
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of the gastro -intestinal tract and inflammatory 
changes of gastric mucosa are factors. They also 
suggest that the vitamin may be hold in oily 
laxatives, as already demonstrated by Jackson (1931) 
with vitamin A. 
(3) Due to leucocytosis. Cuttle (1938) reports 
increased requirements of vitamin C in leukosis, 
and brings evidence to show that this is partially 
due to the increased number of white cells. He 
considers that the leucocytes in infection is a factor. 
(4) Specific increased need for the vitamin is 
certainly very doubtful. 
Lack of adequate intake is of course an obvious 
cause of a hypovitaminosis C and is particularly 
liable to play a part where the appetite is impaired. 
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As regards the possible effects, if any, of 
this state of hypovitaminosis. 
(1) Evidence obtained from the ex erimental animal. 
(a) Spontaneous infections in guinea pigs 
suffering from experimental scurvy. 
Topley and Wilson (1936) quote Hamburger and 
Goldschmidt (1922 - 23), Schmidt, Weyland and 
Koltysch (1927) and Grant (1 °26), who say they are 
common and Holst and Fralich (1912) who state they 
are uncommon. 
(b) Experimental infection in guinea pigs 
suffering from experimental scurvy. 
(i) Tuberculosis 
H8jer (1924), Schutze and 
Zilva (1927) and Grant (1930) have found decreased 
resistance to tuberculosis in guinea pigs in 
hypovitaminosis. IrIouriquand, Rochaise and Dosdet 
(1925) made similar findings. For the first 3 
weeks the resistance of the animals was increased. 
Then it suddenly fell. 
(ii) Other infections. 
Findlay (1923) showed decreased 
resistance to S. aureus, S. haemolyticus, pneumococcus 
and H. coli in scorbutic guinea pigs. Schmidt,. 
- 24 - 
Weyland and Koltsch (1927), quoted Topley and 
Wilson (1936), also found decreased resistance 
to the common infections. 
Robertson (1934) says that there is almost 
unanimous agreement that there is increased 
susceptibility to infection in scurvy both 
spontaneous and experimental. 
In spite of these findings the specific 
immunity reactions are unaffected. Zilva (1919) 
showed that the serum of guinea pigs suffering from 
scurvy after immunization with 3. Typhosus, yielded 
agglutinin and amboceptor titres of the same order, 
as those obtained from the serum of animals 
receiving ample vitamin C. 
(c) Regarding the effects of giving amounts 
of vitamin C above normal. 
Bloch (1935) , Bella (1935) and Heise and 
Martin (1936 - 37) reported no increased resistance 
in the experimental animal on such treatment. 
Steinbach and Klein (1936) found that it increased 
resistance when tuberculin was given in small but 
repeated doses, large enough in the aggregate to 
be fatal for control tuberculous animals. It had 
no effect on skin response to intracutaneous 
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inoculation and no effect when given in a single 
fatal dose. 
Leichtentritt (1924) and Grant (1930) gave 
large amounts of vitamin C to tuberculous guinea 
pigs and noted that it decreased the severity of 
the lesions. 
Madeson and Manwaring (1937 - 38) confirmed 
the results of Jusatz (1936) who reported that 
intravenous injection of a massive dose of ascorbic 
acid in rabbits increased the bactericidal power 
index about twofold and specific precipitation 
product about fivefold. They found, using horse 
serum as an immunizer, prompter formation of 
precipitins in bigger amounts, and that the 
precipitins so formed lasted longer. 
Ascorbic acid does not have a lethal effect 
on the tubercle bacillus. van Gagyi (1936) found 
that tubercle bacilli live for at least 70 hours 
on media containing 5/100 parts of ascorbic acid, 
and their virulence was not changed. Heise and 
St e inken (1937) confirm this. 
Summing up the position we may say that 
scorbutic guinea pigs show increased susceptibility 
to infection including tuberculosis. There is 
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conflicting evidence that intake of ascorbic acid 
above the normal modifies infections in guinea pigs. 
(2) Evidence obtained from human patients. 
(a) The Sub- vitamin C state and infection. 
The sub -vitamin C state in man can be divided 
into two conditions (i) clinical scurvy, i.e. when 
the vitamin C content is insufficient to prevent 
scurvy and (ii) latent scurvy, where the vitamin C 
content is insufficient for complete saturation. 
In clinical scurvy there is a greater tendency 
to infection, which runs a more serious course, and 
if a patient, who is on the verge of scurvy develops 
an infection, he will develop scurvy. 
For example, Hess (1920) quotes from an earlier 
paper of his (1917) "Latent scurvy was prematurely 
changed to florid scurvy by the presence of a ward 
infection; an epidemic of 'grippe" precipitated an 
epidemic of scurvy exceptional in its haemorrhagic 
tendency." Later he states that active pulmonary 
tuberculosis is not an uncommon secondary 
manifestation, that pneumonia is a frequent cause 
of death and that other infections such as pyelitis, 
otitis, adenitis, widespread recurrence of nasal 
diphtheria and "grippe" are common in scurvy in 
infants. 
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Delf (1921) states that the incidence of scurvy 
among the natives in South Africa rises with the 
morbidity from tuberculosis. Frank (1931), in the 
Sudan, found that when adequate vitamin C was given 
an epidemic of pneumonia stopped. Mettier, Minot 
and Townsend ( 1930), Mackay (1934) and Parson's ( 1938) 
observations on children, agree with these findings. 
In the "latent" scurvy state there is no 
evidence that the susceptibility to infection is 
altered. 
Zilva (1937) holds strong views on the subject, 
saying that "There seems therefore to be in human 
subjects also a wide margin of unsaturation, which 
has no obvious detrimental effect on the health of 
the individual. To apply to this zone of 
"uns eturation" such expressions as "hypovitaminosis C; 
"latent or potential scurvy ", "vitamin C subnutrition," 
"subacute scurvy" - expressions which imply ill 
defined pathological conditions - is not justified 
by our present state of knowledge." 
- 28 - 
(b) The effect of giving increased amounts 
of ascorbic acid. 
(i) On susceptibility to infection 
There is no evidence that 
"saturation" of patients decreases their 
susceptibility to infection. 
Wright (1936) giving patients 1,000 mgtn. ascorbic 
acid daily for a long period records that such patients 
developed abscesses, tonsillitis and otitis media. 
Recently Fox, Dangerfield, Gottlich. and Jokl (1940) 
tested the administration of vitamin C to a group 
of native miners, with another similar group as a 
control - 950 in all. 40 mgm daily in excess 
of ordinary intake was given. No evidence of 
protection from infection was obtained. 
(ii) On patients suffering from tuberculosis 
Good results have been claimed for 
the treatment of intestinal tuberculosis with cod 
liver oil and tomato juice, as introduced by McConkey 
(1930). 2 of our 3 cases on such treatment were, 
as shown above, moderately deficient, as are very 
probably many cases on this treatment. 
In pulmonary tuberculosis Radford, de Savitash 
and Sweany (1937) found a greater percentage 
favourable course, as judged by red cell count, 
- 29 - 
haemoglobin, lymphocytes, mononuclears, etc. in 
patients having 500 c.c. fresh orange juice or 
synthetic orange juice plus 25 mgm ascorbic acid 
per day, whereas cases receiving synthetic orange 
juice without ascorbic acid showed no such change, 
but their results are by no means conclusive. 
Vaquette (1937) reports that his patients 
treated with ascorbic acid put on weight, but his 
series of cases is very small. 
Martin and Heise (1937) concluded that there 
was no controlled evidence of effect of ascorbic 
acid therapy on course of pulmonary tuberculosis. 
Josewich. (1939) found their patients showed 
only slight improvement or not at all. There was 
slight improvement in haemorrhagic cases. 
Hurford (1938) treated 42 patients with ascorbic 
acid for varying periods and found significant 
improvement in only 7 patients with microcytic 
anaemia. 
Bakksh and Rabbani (1939) concluded that if 
ascorbic acid is deficient, it is a valuable adjuvant 
to other forms of treatment. Their cases were 
watched only 6 weeks - too short a time. 
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The amount of vitamin C required in healthy 
individuals is relevant here, since the amount 
required in health will have a bearing on amount 
required in disease. 
Harris et al (1936), although they found that 
75% of working class families examined were below 
standard in their vitamin C nutrition (middle and 
professional classes were above) state "A critic 
may argue that the accepted standard is too high, 
but this is a mistaken view. A comparison may justly 
be made with the accepted standard for the intake of 
iron and with the prevalence of "sub- clinical" 
nutritional anaemia. Large numbers of poorer people 
show some degree of nutritional anaemia. They may 
show no clear cut symptoms of illness, yet when extra 
iron is given their general health and fitness improve, 
as evidenced, for example, by their diminished 
morbidity rate. A similar state of affairs may be 
true for vitamin C. In any case an intake of one 
orange a day is more than adequate to bring the intake 
up to the level of the reputed optimum." 
The objection to this argument is that there is 
really no evidence that saturating an individual 
benefits his general health) and that one orange a day 
would represent a considerable relative expenditure 
for a poor person, and, of course, nowadays they are 
- 31 - 
very difficult to obtain. Zilva (1937), as set 
out before, does not agree with Harris. 
Other workers have put the daily requirements 
as considerably higher than Harris. 
Gothlin (1934) by comparing human requirements 
to those required to protect guinea pigs from scurvy, 
gives the daily requirements of a man, weighing 60 kgm 
to protect against slightest ascertainable prescorbutic 
alteration - those in the capillaries - as 
19 - 27 mgm. 
van Eekelen (1936) ' put patients on a diet low 
in vitamin C and then saturated them. The amount 
required to saturate, minus amount of ascorbic acid 
excreted above daily average during last few days, 
divided by number of days on low diet, gives the 
daily requirements. It worked out at 60 mgm,, per 
70 kgm. b ody weight. 
Heinemann (1936) using similar technique 
obtained a similar figure. 
Such daily requirements are even more a council 
of perfection - representing more than 2 oranges 
daily. 
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What then should be the attitude to the low 
levels of vitamin C in pulmonary tuberculosis? 
As shown those patients with active pulmonary 
tuberculosis and those with pyrexia complicating 
the disease use much larger amounts of ascorbic 
acid than healthy individuals. Therefore it would 
appear to be rational to give them extra amounts of 
ascorbic acid, optionally keeping them saturated, 
in spite of the inconclusive evidence of this 
improving their condition. 
In intestinal tuberculosis, where McConkey's 
regime of tomato juice and cod liver oil is given, 
in order to obtain the maximum benefit from such 
treatment the patients should be saturated with 
ascorbic acid. 
Heise and Martin (1936) have shown that tuberculous 
patients require up to 138 mgrs. per day and Heinemann 
(1938) has shown that febrile patients require 80 to 
110 mgm.daily, so probably 100 mgm would be ample plus 
ordinary diet. 
In afebrile patients the diet should be 
investigated and if it is low in vitamin C this 
should be corrected. 
Accurately to maintain saturation van Eekelen's 
(1936) method, or the method suggested by Heinemann 
(1938) may be used. He suggests a preliminary 
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analysis of whole blood. With 8 mgm per litre 
concentration about 1,000 mgm. ascorbic acid is 
necessary to produce saturation. Aith 4 mgm per 
litre concentration about 2,000 mgm, is necessary. 
The amount presumably required is supplied in doses 
of 250 - 300 mgm. Then after an interval of 
about 12 hours the concentration of ascorbic acid 
in whole blood is determined. It should be about 
10 - 12 mgm, per litre. 0.8 mgm, per kgm ,of body 
weight is given daily for one week and the blood 
examinat ion repeated. 
The simplified saturation test technique of 
Harris and Abbasy (1937X might be used where 3 hour 
(from 9 a.m. to noon) specimens of urine are tested, 
each 3 hour specimen equalling fairly accurately 
á total day's excretion. Test doses of vitamin 
are given as in the ordinary saturation test. 
The ascorbic acid may be given as synthetic 
ascorbic acid in tablet form, each tablet containing 
25 mgm., or in fresh fruit when in season, green 
vegetables and, if available, oranges. 100 mgm. 
daily would be difficult to obtain by eating vegetables, 
so that much of it would have to be given in tablets. 
- 34 - 
The saturation test does not appear to be 
worth while doing to find the activity of a patient's 
disease. The usual methods of physical signs, 
temperature, pulse, blood sedimentation rate and 
X ray findings are easier to perform and more valuable. 
Summary 
(1) 35 patients suffering from pulmonary 
tuberculosis were investigated regarding their 
vitamin C nutrition by urinary excretion and 
saturation tests. 
(2) A hypovitaminosis C was found in many, 
greater in febrile patients with active disease. 
(3) The average daily excretion test is shown 
to be unsatisfactory for testing febrile pulmonary 
tuberculous patients. 
(4) The results of the workers in this field 
are reviewed. 
(5) The possible causes of this hypovitaminosis 
C are mentioned. 
(6) The effects of a deficiency or excess of 
vitamin C are considered, it being concluded that 
on the whole, if marked, the deficiency will have 
a deleterious effect, 
1#04411.08100401.41 ialW614. 
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(7) The application of these findings to cases 
of pulmonary tuberculosis is considered. 
Febrile patients with active disease should receive 
100 mgm.ascorbic acid daily in addition to their 
ordinary diet. 
Non -febrile patients should receive plenty of 
green vegetables and, if possible, fresh fruit. 
My thanks are due to Dr. H. G. Tra.yer, 
medical Superintendent, Baguley Sanatorium, Cheshire, 
for permission to investigate the cases which were 
under his care, and to Roche Products, Ltd., for 
a generous free supply of ascorbic acid and 
2 : 6 dichlorphenolindophenol tablets. 
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22.2.32. Cough many years. Intestinal and 
abdominal tuberculosis. T.B. rt. hip. Not 
much disease in chest. Abdomen troubling 
her monthly. Temp. 97- 100.5: Pulse 84 -108. 
TBf3. B.S.R. 19. 






per 12 of Titration 












24 486 1/5 
686 1/2 
25 114 1/2 
X 800 1 /10 
26 1600 1 /10 
Aver- Ascor- 
age bic ac. 
Titra- excretn 
tion per day Total 
mgm 
.90 .98 .92 .90 25.4 
.56 .54 .58 .56 16.3 41.7 
1.01 1.03 1.01 1.02 10.7 
.80 .84 .84 .83 19.4 30.1 
.98 .98 1.00 .99 12.2 
.50 .50 .51 .50 20.3 32.5 
.90 .91 .88 .89 5.1 
.64 .61 .62 .62 10.2 15.3 
1.11 1.12 1.13 1.12 9.1 
.94 .91 .96 .95 11.5 20.6 
1.06 1.01 1.06 1.04 16.5 
.96 .95 .95 .95 15.8 32.3 
.86 .85 .66 .86 3.2 
.76 .76 .78 .77 114.0 
.50 .54 .52 .52 340.0 454.0 
Average daily excretion 28.8 mgm. Average daily excretion 















486 1/2 .78 .80 .80 .79 13.8 
1825 1/2 1.16 1.14 1.17 1.16 35.0 48.8 
1143 1/4 .84 .90 .86 .87 56.2 
170u 1/3 .92 .91 .88 .90 62.4 128.6 
12u .66 .66 .64 .65 2.0 
52u 1/5 .70 .71 .73 .71 41.0 43.0 
680 .50 .49 .49 .49 15.4 
100 1/3 .88 .88 .88 .88 4.7 20.1 
400 1/3 1.13 1.13 1.13 1.13 1.7 
320 .76 .76 .79 .77 4.7 6.4 
400 1/6 .84 .81 .84 .83 38.4 
2 120 1.07 1.10 1.12 1.10 21.4 59.8 
160 1/2 .84 .86 .84 .85 4.2 
1480 .76 .79 .81 .79 20.8 25.0 
892 .88 .89 .89 .89 11.0 
X 300 1/40 .96 .94 .94 .95 141.0 
760 1/20 1.20 1.19 1.18 1.19 141.6 293.6 
daily excretion 51.3 mgm. Average daily excretion 




°t'')"1 ,6r,,e1 w-( 







Summary of Admitted 19.5.38. Cough 1 yr. General condition 
history: poor. TB*3. iii+ sputum. Moderate bilateral 
disease. Temp. 97 -100. Pulse 88 -96. B.S.R. 18. 


















































































age bic ac. 
Titra- excretn 




















.86 42.5 61.5 
.66 45.7 
1.48 311.1 
1.20 190.0 501.1 
Average daily excretion 104.6 mgm. Average daily excretion 
per 10 stone body weight 119 mgm. One day to become satu- 
rated. 
Aug. 
19 914 1.60 1.65 1.63 1.63 6.2 
1714 1.88 1.90 1.93 1.90 10.9 17.1 
20 914 1.08 1.11 1.11 1.10 9.1 
1029 .91 .91 .88 .90 12.5 21.6 
21 1029 .88 .90 .92 .90 12.8 
1744 1.77 1.78 1.80 1.78 12.8 25.6 
22 1429 .65 .66 .66 .66 23.8 
800 1.22 1.25 1.26 1.24 7.3 31.1 
23 914 .76 .75 .75 .75 13.4 
800 1.59 1.62 1.60 1.60 5.5 18.9 
24 1614 .63 .63 .61 .63 28.0 
971 1.50 1.49 1.52 1.50 7.2 35.2 
25 543 .70 .74 .73 .72 8.4 
571 1/5 .53 .55 .56 .55 58.0 66.4 
26 457 .66 .65 .63 .65 7.9 
X1029 1/10 .73 .75 .72 .73 156.0 
27 800 1/10 .81 .80 .78 .80 112.0 268.0 
Average daily excretion 30.8 mgm. Average daily excretion 
per 10 stone body weight 35.3 mgm. One day to become satu- 
rated. 
I- 
I ^iw-A Otw-1y -4.c-<- r+-. I L 4 , n..4, 





Admitted 7.6.38. History lasting one year - 
cough, loss of weight, etc. Left upper lobe 
cavitation. Left artificial pneumothorax 
induced April. Poor collapse. General con- 
dition poor. Sputum Esst T54-2. Temp. 97 -100. 
Pulse 98 -112. B.S.R. 14. 
,,eight 7st 51ós. Dose of ascorbic acid 500 mgm. Diet ++ 
Amount Dilu- 
urine tion 
per 12 of Titration 
1938. hours urine Readings 
July c.c. 
3 
Aver- As cop - 
age bic ac. 
Titra- excretn 
tion per day Total 
mgm 
0 343 .99 .96 .99 .98 4.0 
857 1.27 1.29 1.32 1.29 7.4 11.4 
31 457 1.83 1.83 1.84 1.83 2.8 

















.85 .84 .87 .85 5.2 
114 1.18 1.19 1.20 1.19 1.0 6.2 
3 457 .82 .80 .84 .82 6.1 
1142 1.21 1.22 1.22 1.22 10.1 16.2 
4 1086 1.08 1.10 1.10 1.10 11.1 
571 1.14 1.16 1.18 1.16 5.7 16.8 
5 457 1.94 1.97 1.95 1.95 2.1 
X1143 1/2U .89 .88 .90 .89 142.8 
6 457 1/20 .87 .86 .88 .87 58.6 201.4 
Average daily excretion 8.5 mgm. Average daily excretion 
per 10 stone body weight 11.4 mgm. One day to become satu- 
rated. 
0 












4.8.38. Cough 4 years. General condition poor. 
iii+ TB +2. Extensive bilateral disease with 
cavitation. Temp. 97- 100.5: Pulse 80 -104 
B.S.R. 17. 
r Height 6st. lib. Dose of ascorbic acid 450 mgm. Diet 
Amount Dilu- Aver- Ascor- 
age bic ac. 
urine of Titration Titra- excretn 
1938. 12 hrs urine Readings tion per day Total 
Sept. c.c. mgm 
22 343 .84 .86 .87 .86 6.0 
1029 .64 .70 .69 .68 16.8 22.8 
23 571 .57 .59 .61 .5.9 10.6 
1270 .62 .64 .66 .64 22.0 32.6 
24 520 1/2 .92 .90 .96 .93 12.4 
440 1/3 .76 .77 .77 .77 48.0 60.4 
25 480 .76 .77 .78 .77 6.9 
200 1/2 .88 .88 .89 .88 5.0 11.9 
26 800 .90 .88 .88 .89 19.0 
380 1/3 .64 .66 .64 .65 20.5 39,5 
27 200 1.39 1.37 1.34 1.37 1.6 
160 .56 .58 .58 .57 3.1 4.7 
28 400 1/2 .97 .96 .94 .96 8.2 
Nil 8.2 
29 200 1/2 .84 .82 .83 .83 5.3 
;Ni1 
30 150 1/20 .65 .66 .65 .65 40.0 40.0 
215 1/40 .72 .74 .68 . .71 134.4 
Oct.]. 520 1/40 .70 .69 .69 .69 345.2 479.6 
Average daily excretion 28.9 mgm. Average daily excretion 
















.86 .86 .87 
1/2 .76 .78 .78 
1/4 .82 .80 .82 
.88 .90 .88 
.59 .59 .60 
1/2 1.58 1.61 1.61 
1/2 1.10 1.08 1.09 
1.08 108-1.07 
1/2 .90 .91 .90 
1/2 1.48 1.50 1.51 
1/2 1.36 1.37 1.40 
1.05 1.07 1.08 
.86 10.0 
.77 16.6 26.6 
.81 17,2 
.89 1.7 18.9 
.59 3.8 
1.60 4.3 8.1 
1.09 5.5 
1.08 2,3 7.8 
.90 7.8 
1.50 5.0 12.8 
1.38 3.2 
1.07 3.8 7,0 
X780 1 /10 .71 .71 .70 .71 122.0 
16 320 1 /10 .96 .97 .97 .97 37.0 159.0 
760 1 /10 .66 .66 .68 .67 127.0 
17 200 1 /10 .62 .63 .64 .63 35.0 162.0 
552 1/60 .98 1.00 1.00. .99 372.0 
18 200 1/40 1.04 1.06 1.06 1.05 84.0 456.0 
Average daily excretion 13.6 mgm. Average daily excretion 
per 10 stone body weight 22.6 mgm. Days to become saturated 3. 












Admitted 19.5.38. Cough since winter. 
Staining December. Extensive disease 
throughout L. lung. Infiltration rt. apex & 
base. 
TPfi3. Temp. 97 -102. Pulse 96 -130. B.S.R.32. 
Died 15.8.38. 
101bs. Dose of ascorbic acid 500 mgm. Diet+ 
Amount Dilu- 
urine tion 
per 12 of 
1938. hours urine i y c.c. Titration Readings 
Aver- Ascor- 
age bic ac. 
Titra- excretn 
tion per day Total 
mgm 
30 628 1/2 .62 .68 .65 .65 21.6 
114 .76 .77 .77 .77 1.5 23.1. 
31 343 .64 .62 .62 .63 6.0 
229 .77 .75 .76 .76 3.4 9.4 
Aug.1 600 .62 .60 .58 .60 11.1 
.73 .76 .75 .75 6.8 17.9 
2 457 .49 .50 .50 .50 13.0 
329 .54 .53 .56 .54 4.7 17.7 
3 343 .91 9.0 
1143 .74 .76 .72 .74 17.3 26.3 
4 with faeces 
457 .87 .90 .90 .88 14.2 14.2+ 
5 228 .57 .57 .60 .58 4.4 
286 .50 .50 .52 .51 7.4 
6 343 1/20 1.32 1.32 1.34 1.32 28.0 35.4 
571 1/20 1.36 1.36 1.35 1.36 102.0 
7 457 1/20 .92 .87 .88 .88 57.8 159.8 
228 1/40 .80 .77 .77 .78 116.0 
8 457 1 /20 .86 .88 .85 .86 115.0 231.0 
Average daily excretion 16.7 mgm. Average daily excretion 
per lu stone body weight 21.6 mgm. Days taken to become 





5.9.38. Cough 6 years. General condition poor. 
iiv+ Temp. 97 -101. Pulse 84 -114. B.S.R. 22. 
Cavitation left upper lobe and extensive infil- 
tration right upper lobe. TB +2. 





stones. Dose of ascorbic acid 
Dilu-Aver- 
tion age 
of Titration Titra- 
urine Readings tion 




per day Total 
mgm ct. c.c. 
5 390 .68 .66 .66 .67 6.5 
390 1.32 1.36 1.38 1.35 3.3 9.8 
6 400 .86 .90 .88 .88 5.1 
60 1/3 .72 .73 .72 .72 2.8 8.9 
7 400 .57 .55 .56 .56 8.0 
60 1.58 1.62 1.64 1.61 0.4 8.4 
8 370 .98 1.00 .99 .99 4.2 
480 2.90 2.95 2.97 2.94 1.9 6.1 
9 330 1.10 1.11 1.08 1.10 3.4 
610 2.86 2.88 2.89 2.88 2.3 5.7 
2.37 2.30 
270 2.87 2.73 2.77 2.79 1.1 3.9 
11 130 1.72 1.76 1.78 1.75 .9 
X 370 1/5 .83 .84 .84 .84 21.6 
12 450 1/2 .98 .98 .96 .97 11.3 32.9 
120 1/20 1.02 1.01 .99 1.00 26.0 
13 630 1/20 1.84 1.87 1.85 1.85 76.0 102.0 
810 1/20 .52 .54 .52 .53 343.0 343.0 
Average daily excretion 6.9 mgm. Average daily excretion 
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17.3.38. Ox+ TBt3. Cough, spit, wea'mess, one year. 
T.B. larynx and intestinal tuberculosis 5 weeks. 
Extreme bilateral disease with cavitation. Persis- 
tent diarrhoea. Larynx gross ulceration. Temp.97 -102 
Pulse 90 -110. B.S.R. 24. 
Weight about 8 stones. Dose of ascorbic acid 550 mgm. Diet 
average. *ss tomato juice and cod liver oil daily. 
Amount Dilu- 
urine tion 
per 12 of 




Aver- As cor - 
age bic ac. 
Titra- excretn 
tion per day Total 
mgm 
23 252 .5cc .94 .97 .95 .95 1.3 
320 .1/4 1.49 1.50 1.52 1.50 8.4 9.7 
24 600 1.88 1.86 1.88 1.87 7.0 
120. 1.28 1.28 1.29 1.28 .5 7.5 
25 400 .5cc .49 .51 .54 .51 4.5 
600 " .89 .90 .91 .90 3.7 8.2 
27 600 " 1.61 1.58 1.61 1.60 2.6 
400 1.33 1.34 1.36 1.34 3.3 5.9 
28 400 .59 .59 .57 .58 3.3 
740 .65 .64 .67 .65 12.5 15.8 
29 454 .62 .62 .61 .62 8.2 
X 272 1.00 1.00 .98 1.00 3.0 
30 600 .53 .51 .54 .53 12.5 15.5 
332 1/20 .88 .88 .86 .87 84 
31 Los t 84+ 
1232 1/25 .84 .84 .81 .83 410.0 
Augl 300 1/25 1.27 1.27 1.30 1.29 65.0 475.0 
Average daily excretion 92 mgm. Average daily excretion 
per 10 stone body weight 11.5 mgm. o days to become sat- 
urated. {"` 





15 .1.38. 6 months history. Ei+ TB +3 
Developed serous effused extensive generalised 
disease left lung with cavitation upper lobe. 
Artificial pneumothorax 25.1.38. -23.3.38. 
Larynx 26.7.38. Temp. 97 -99.7. Pulse 84 -100, 
B.S.R. 24. 































































































































































Average daily excretion 38.8 mgm. Average daily excretion 




26 240 .86 .86 .87 .86 6.1 
300 .69 .68 .68 .68 5.7 11.8 
27 320 .56 .56 .55 .56 6.4 
520 1/3 1.04 1.01 1.04 1.03 16.2 22.6 
28 540 1/3 1.05 1.02 1.01 1.03 17.4 
760 1/3 1.38 1.39 1.36 1.38 18.3 35.7 
29 360 1/6 1.28 1.29 1.31 1.29 18.1 
160 1.10 1.11 1.12 1.11 1.6 19.7 
30 380 1/2 1.56 1.57 1.52 1.55 5.4 
520 1/2 1.03 1.04 1.04 1.04 2.7 8.1 
31 220 1/2 1.47 1.48 1.48 1.48 3.4 




I 2 S- G IU 
Ramps on . 
Summary of 
history: 
Six months history of cough. Scattered 
bilateral disease with cavitation. Oi of 
positive sputum. Deveoped tuberculosis 
of larynx 19.5.38. Temp. 97 -101. Pulse 88 -110. 
B.S.R. 16.5. 
Weight about 7 stones. Dose of ascorbic acid 500 mgm. Diet+ 
Amount Dilu- 
iarine tion 
per 12 of 















Aver- As cor - 
age bic ac. 
Titra - excretn 
tion per day Total 
c.c. mgrn . 
228 1.71 1.65 1.69 1.67 1.4 
629 1.79 1.73 1.76 1.76 3.9 5.3 
571 .5cc 1.75 1.75 1.80 1.47 2.2 
771 1.03 .97 .99 1.00 8.5 10.7 
314 .59 .55 .54 .56 6.3 
486 .05 .90 .92 .92 5.8 12.1 
628 .71 .70 .74 .73 9.6 
414 .62 .64 .68 .64 7.2 16.8 
457 .98 .97 .98 .98 5.2 
371 .69 .69 .67 .68 6.1 11.3 
457 1.20 1.21 1.17 1.93 4.3 
571 1.89 1.92 1.86 1.89 3.6 7.9 
714 1.33 1.35 1.33 1.34 5.9 
H1270 .74 .70 .73 .72 19.6 
543 .65 .66 .65 .65 9.4 29.0 
771 1/10 1.28 1.24 1.26 1.26 68.0 
628 1/2 .60 .56 .59 .58 12.0 80.0 
457 1/10 2.37 2.40 2.44 2.40 21.0 
571 1/10 1.06 1.07 1.08. 1.07 63.0 84.0 
600 1/20 1.11 1.13 1.14 1.13 119.0 
686 1/20 .57 .59 .57 .58 264.0 383.0 
Average daily excretion 10.5 mgm. Average daily excretion 
per 10 stone body weight 15 mgm. Days to become saturated --4. 
a`"f ``"....2e1 A p l*,we 
ir "'i'n . 
(,4, . 







Patient from 30.11.36. -29.4.37. 26.8.37.- 21.10.37. 
7.7.38.-onwards. Bronchitis 4 yrs. Sever pneumo- 
thorax 25.12.37. TB +3. Temp. 9'7 -99. Pulse 80 -100. 
B.S.R. 26. Bilateral fibrotic disease with cavi- 
tation. Took discharge 10.8.38. against advice. 
























age bic ac. 
Titra- excretn 
tion per day Total 
mgm 
224 .96 .94 .90 .94 2.7 
1080 1.22 1.18 1.21 1.22 4.9 7.6 
580 1.27 1.29 1.31 1.29 ' 2 .5 
600 .5cc .60 .61 .63 .61 5.4 7.9 
200 .52 .53 .52 .52 4.3 
600 .5cc 1.18 1.20 1.21 1.19 2.8 7.1 





































X 800 .98 1.02 1.01 1.00 8.9 
680 .5cc .96 .95 .95 .95 3.9 12.8 
280 1.35 1.35 1.36 1.35 1.2 
680 .92 .90 .94 .92 8.4 9.6 
320 .65 .65 .67 .66 5.5 
Lost 5.5+ 
700 1/5 .64 .61 .60 .62 63.6 
800 1/20 .72 .75 .74 .74 24.6 88.2 
800 1/5 1.22 1.21 1.19 1.21 44.4 
600 1.00 1. 05 1.05 1-.03 6.4 5 0. 8 
700 .79 .80 .79 .79 9.8 
220 1.94 1.92 1.94 1.93 1.3 11.1 
800 1.20 1.21 1.20 1.20 4.1 
Average daily excretion 6.8 mgm. Average daily excretion 






















Admitted 15.9.38. History of 16 months. 
Poor condition. Great loss of weight. 
sputum. Temp. 97- 101.5: Pulse 110 -112. 
Extensive bilateral disease. TB1-3. B.S.R.26.5 
Enteritis. 


























.67 .65 .68 
.59 .61 .64 
.64 .61 .62 
.51 .55 .53 
.82 .84 .84 
1.43 1.46 1.44 
.70 .73 .71 
.62 .63 .64 
.54 .56 .54 
.95 .95 .97 
.60 .63 .65 
1.17 1.18 1.20 
.54 .54 .53 
.86 .86 .87 
1.97 2.04 2.03 
1.13 1.17 1.15 
.60 .58 .61 
.96 .96 .95 
.53 .54 .53 
.6M .64 .6M 
1.36 1.36 1.38 
1.77 1.77 1.75 
1.02 1.02 1.02 
.69 .68 .69 
.82 .79 .80 







































































































Average daily excretion 6.8 mgm. Average daily excretion 
per 10 stone body weight 7.6 mgm. Days to become satu- 








Summary.of Cough for many years. Bilateral disease 
history: with cavitation. Temperature rising to 100. 
B.S.R. 30. Toot discharge against advice. 
eight 6st 1 -lb. Dose of ascorbic acid 550 mgm. Diet+ 
Amount Dilu- 
urine tion 
per 12 of 




Aver- tes cor - 
age bic ac. 
Titra- excretn 




























8 249 .65 .70 .73 .69 
471 1.43 1.34 1.40 1.39 
9 264 1.24 1.18 1.16 1.19 
817 1.00 0.84 0.74 .86 
11 469 .84 .85 1.04 .94 
220 .83 .82 .79 .81 
12 400 .90 .92 .73 .85 
497 .79 .79 .86 .81 
13 243 .78 .77 .79 .78 
439 1.11 1.02 1.02 1.05 
14 272 .71 .73 .71 .72 
714 1.10 1.09 1.24 1.14 
15 346 1.32 1.14 1.23 1.23 
346 .95 .92 .95 .93 
16 X349 .80 .82 .82 .81 
408 .93 .83 .74 .83 
17 157 .84 .80 .86 .83 
229 .80 .84 .82 .82 
18 257 .55 .56 .50 .54 
457 1/6 .90 1.10 .91 1.00 
19 400 1/5 1.47 1.46 1.44 1.46 
343 1/2 .90 1.00 1.50 1.13 
20 400 1/3 1.18 1.17 1.12 1.15 
243 1/4 1.89 1.93 1.96 1.93 
21 300 1/5 1.91 1.92 1.93 1.92 
86 .50 .50 .51 .50 
- Average daily excretion 8.1 mgm. Average daily excretion 
per 10 stone body weight 13.5 mgm. Days to become satu- 





3 e IS 
Nuttal. 
Summary Patient from 6.3.,56 -- 5.11.36 and from 
of history: 10.5.37 -- 30.9.38. (Died) . 1953. Cough, 
loss of wt. etc. Bilateral cavitation. 
Old larynx. Now very ill. Persistent 
temperature of 97 -99.5. Pulse 98 -100, 
since admission. B.S.R. 26. 
eight 8st 2lbs. Dose of ascorbic acid 550 mgm. Diet: Mil 
deficient 
Amount Dilu- Aver- Ascol- 
urine tion age bic ac. 
per 12 of Titration Titra- excretn 
1938. hours urine Readings tion per day Total 
July. c.c. 
23 300 .5cc 
350 lee 



























Augi 108 1/10 
150 1/5 
2 160 .5cc 
224 1/20 
3 368 1/25 
328.61,.1/25 
































































































































Average daily excretion 5.8 mgm. Average daily excretion 
per 10 stone body weight 7.0 mgm. Days to become saturated 
Se pt . 
23 1.25 1.28 1.32 1.28 4.6 540 
914 2.42 2.33 2.38 2.38 4.3 8.9 
24 1.06 1.08 1.08 1.07 5.9 571 
686 1.40 1.44 1.45 1.43 5.3 11.2 
25 .91 .95 194 .93 4.1 343 
171 1.39 1.41 1.43 1.41 1.3 5.4 
26 1.26 1.27 1.25 1.26 4.0 457 
#457 1.51 1.50 1.53 1.51 3.3 
27 .98 1.00 1.00 .99 . 5.8 9.1 457 
457 1.21 1.23 1.26 1.23 4.1 
28 1.19 1.20 1.20 1.20 5.9 10.0 629 
457 1.34 1.33 1.37 1.35 5.0 




Amount Dilu- Aver- Ascor- 
urine tion age bic ac. 
per 12 of Titration Titra- excretn 
hours. urine Readings tion per day Total 
mgm 1938. c.c. 
Sept. 
29 343 1 /10 1.19 1.21 1.23 1.21 31.7 
30 457 1/20 1.57 1.50 1.55 1.54 66.0 97.7 
Death. 
Avergge daily excretion 8.5 mgm. Average daily excretion 
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1 3 ti á 4) S 
Groom. 
Summary of 3 years history. Cachectic on admission. 
history: Extensive bilEteral disePse. 
Temp. 97 -101. Pulse 88 -112. B.S.R. not done. 
Weight about 9st. Dose of ascorbic acid 600 mgrn. Diet sli;htly 
low. 
Amount Dilu- Aver- Ascor- 
urine tion age bic ac. 
per 12 of Titration Titri- excretn 
1938. hours urine Readings tion per day Total 
July c .c. mgm 
18 343 .86 .86 .84 .85 4.4 
286 1/3 .99 .95 .97 .97 4.8 9.2 
19 200 1.10 1.08 1.12 1.10 2.7 
342 1.09 1.11 1.13 1.11 3.5 6.2 
21 343 1.00 1.01 1.01 1.01 3.7 
399 .76 .75 .75 .75 5.9 9.6 
22 429 .72 .76 .76 .75 6.5 
286 1.14 1.10 1.10 1.11 2.8 9.3 
23 1.24 1.26 1.45 1.32 3.7 
571 1.03 1.06 1.08 1.06 6.1 9.8 
24 171 1.05 1.06 1.07 1.06 2.1 
A171 1.34 1.33 1.33 1.33 1.4 
25 657 .60 .63 .61 .61 12.1 13.5 
143 .88 .90 .91 .90 1.8 
26 342 .74 .73 .79 .77 5.0 6.8 
510 1.22 1.24 1.27 1.24 4.6 
27 742 .64 .65 .64 .64 13.0 17.6 
771 1.15 1.16 1.15 1.15 7.5 
28 600 .77 .74 .75 .75 8.9 16.4 
686 1/5 1.62 1.65 1.63 1.63 19.5 
29 857 1/5 .82 .86 .87 .85 25.0 44.5 
799 1/10 1.28 1.30 1.31 1.30 68.0 
30 799 1 /10 1.58 1.64 1.68 1.64 55.0 123.0 
1143 1/20 .77 .77 .73 .76 336.0 
31 686 1/20 .66 .62 .67 .65 236.0 572.0 
Average daily excretion 8.8 mgm. Average daily excretion 




















1.12 1.16 1.12 1.13 9.0 
1.42 1.47 1.45 1.45 3.5 12.5 
.72 .73 .75 .73 13.9 
.69 .72 .74 .72 3.6 17.5 
.63 .64 .64 .64 6.0 
1.19 1.16 1.17 1.17 6.6 12.6 
.70 .67 .66 .68 8.4 
1.06 1.07 1.07 1.07 2.4 10.8 
.65 .67 .67 .66 15.2 
1.15 1.16 1.16 1.16 3 .3 18.5 
.61 .60 .61 .61 10.5 





















per day Total 
c .c. mgm 
30 457 .64 .68 .67 .66 9.1 
X 457 .79 .81 .80 .80 6.3 
31 686 .95 .91 .96 .94 8.0 14.3 
571 2.14 2.29 2.25 2.29 2.7 
Sepl 229 .71 .68 .71 .70 3.6 6.3 
686 1.93 1.94 1.99 1.95 3.3 
2 571 2.65 2.71 2.73 2.69 2.4 5.7 
800 .78 .78 .77 .78 11.4 
3 571 .78 .78 .79 .78 24.3 35.7 
571 1.79 1.59 1.69 1.69 11.3 
4 800 1.44 1.31 1.30 1.35 17.3 28.6 
229 1.85 1.95 1.93 1.91 4.0 
5 229 1.41 1.50 1.41 1.44 5.3 9.3 
457 1.29 1.36 1.22 1.29 11.8 
6 1143 1.44 1.45 1.46 1.45 17.6 29.4 
350 1.03 1.12 1.06 1.07 72.8 
7 343 1.31 1.32 1.29 1.31 14.6 87.4 
343 1/20 .60 .62 .64 .62 122.0 
8 457 1/20 .88 .90 .94 .91 202.0 324.0 
Average daily excretion 18.9 mgm. Average daily excretion 
per 10 stone body weight 21.0 Days to become saturated 8. 
2a. 














11.6.36. Cough 6 months. TB +2 Eij 
anorexia and occasional vomiting. 
Temp. 97- 100.5. B.S.R. 30. Enteritis. 
Weight 8st. 9lbs. Dose of ascorbic acid 650 mgm. Diet 4ßw 
Amount Dilu- 
urine tion 
per 12 of 








As e or- 
bic ac. 
excretn 
per dam Total 
TUTY c.c. mgm 
19 475 .71 .70 .75 .72 3.6 
1000 3.50 3.30 3.30 3.39 3.3 6.9 
21 425 .68 .71 .68 .69 3.4 
1525 3.64 3.71 3.67 3.67 2.2 5.6 
22 475 .93 .93 .92 .93 5.2 
1025 3.74 3.56 3.63 3.64 1.6 6.8 
23 450 .60 .60 .59 .61 3.4 
580 .93 .95 .97 .95 3.3 6.7 
24 248 .60 .63 .58 .60 2.3 
476 .98 .98 .96 .97 2.7 5.0 
25 400 .50 .51 .53 .51 4.1 
440 .76 .75 .77 .76 3.3 7.4 
27 500 .91 .92 .88 .90 3.1 
932 1.11 1.11 1.08 1.10 4.6 8.7 
28 476 .77 .77 .75 .76 3.4 
H650 .59 .61 .62 .61 10.9 
29 100 .69 .69 .70 .69 1.6 11.5 
728 1.19 1.21 1.21 1.20 6.7 
30 552 .58 .56 .58 .57 10.8 17.5 
844 .85 .91 .90 .88 5.4 
31 1380 1.47 1.43 1.46 1.45 5.3 10.7 
475 .93 .93 .92 .93 5.2 
Aug 1 400 .91 .92 .92 .92 4.9 10.1 
1608 .57 .58 .57 .57 31.0 
2 820 .95 .99 .98 .97 9.4 40.4 
500 1.08 1.08 1.09 1.08 5.1 
3 652 .45 .45 .45 .45 16.0 21.1 
1268 1.29 1.28 1.30 1.29 5.6 
4 480 1/25 .76 .78 .75 .76 172.5 178.1 
560 1/25 1.08 1.09 1.11 1.09 413.9 
5 700 1/25 .98 .97 1.01 .99 442.7 856.6 
Average daily excretion 6.9 m6m. Average daily excretion 
per 10 stone body weight 7.9 mgm. Days to become saturated 8. 
Aug. 
19 200 .72 .73 .71 .72 3.1 
556 .70 .68 .66 .68 9.1 12.2 
20 672 .51 .51 .54 .52 14.3 
1216 1.78 1.77 1.78 1.78 7.6 21.9 
21 672 1/2 .80 .80 .80 .80 18.9 
628 .53 .53 .52 .53 13.4 32.3 
22 200 1/2 .80 .82 .80 .81 4.8 
860 1.19 1.27 1.24 1.23 8.6 13.4 
- continued 



















Aug. c.c. mgm 
23 420 .54 .56 .56 .55 8.3 
880 1.66 1.65 1.67 1.66 5.9 14.2 
24 780 1/2 .91 .90 .88 .90 19.4 
536 .81 .82 .80 .81 9.9 29.3 
25 464 1/2 .72 .68 .70 .70 14.7 
A1344 .96 .95 .95 .95 15.6 
26 360 1 /10 1.95 2.00 2.05 2.00 20.0 35.6 
1036 1.86 1.82 1.85 1.84 6.3 
27 460 1/2 .88 .88 .88 .88 10.6 16.9 
480 1/5 .72 .69 .69 .70 38.0 
28 300 1/20 .67 .70 .71 .69 96.4 134.4 
856 1/20 .83 .87 .84 .85 225.0 
29 360 1/10 .61 .61 .62 .61 65.0 290.0 
Average daily excretion 22.2 mgrn. Average daily excretion 
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Summary of Cough, sputum, night sweats, loss of weight, 
history: 18 months. Cavitntion L. upper lobe. L. APT 
2/3/38. Unsatisfactory collapse. Lss+ s utum 




7st. 7lbs. Dose of ascorbic acid 500 mgm. Diet ++ 
Amount Dilu- Aver- Ascor- 
urine tion age bic ac. 
per 12 of Titration Titra- excretn 
hours urine Readings tion per day Total 
Oct. c.c. mgm 
13 740 1.31 1.33 1.32 1.32 6.2 
500 1.14 1.13 1.15 1.14 4.9 11.1 
14 1100 1.23 1.29 1.25 1.26 9.7 
340 1.36 1.38 1.39 1.38 2.6 12.3 
15 660 .95 .97 .97 .96 7.6 
360 .90 .88 .87 .88 4.5 12.1 
16 600 .67 .65 .69 .67 10.0 
580 1.30 1.29 1.27 1.29 5.0 15.0 
17 600 1.68 1.68 1.70 1.69 4.5 
292 1.33 1.34 1.34 1.34 2.4 6.9 
18 200 .86 .84 .86 .85 2.5 
720 1.32 1.34 1.35 1.33 6.0 8.5 
19 340 1.26 1.24 1.29 1.26 2.9 
320 1.23 1.21 1.24 1.23 2.9 
20 720 1.04 1.08 1.07 1.06 7.5 10.4 
500 .94 .97 .95 .95 5.8 
21 300 .58 .56 .56 .57 5.8 11.6 
280 1/5 1.16 1.14 1.12 1.14 12.5 
22 400 1.02 1.02 1.01 1.02 4.4 16.9 
320 .84 .81 .82 .82 4.3 
23 200 1.50 1.51 1.51 1.50 1.5 5.8 
120 1/20 .57 .52 .50 .53 62.0 
24 200 1/20 1.92 1.88 1.89 1.90 23.4 75.4 
480 1/20 .59 .61 .61 ..60 178.0 
25 Nil 
100 1/8 1.19 1.18 1.18 1.18 56.4 
26 300 1/40 1.20 1.16 1.20 1.17 112.0 168.4 
120 1/40 .68 .70 .72 ..70 76.0 
27 700 1/20 1.12 1.11 1.10 1.11 140.0 216.0 
520 1/50 1.16 1.14 1.15 1.15 252.5 
28 200 1/150 1.68 1.70 1.69 1.69 207.0 459.5 
Average daily excretion 10.9 mgm. Average daily excretion 
per 10 stones body weight 14.5 mgm. Days to become satu- 









Cough and little sputum for past 8 montas. 
Cavitation upper lobe rt. lung. APT with 
fair collapse. Some recent spread mid zone L. 
No sputum. B.S.R. 15. 
Weight lOst. 101bs. Dose of ascorbic acid 600 mgm. Diet+ 
Amount Dilu- 
urine tion 
per 12 of Titration 











17 344 .62 .62 .61 _62 6.0 
800 .73 .80 .66 .73 11.9 17.9 
18 510 .77 .68 .75 .73 7.5 
1000 .88 .86 10.3 17.8 
19 543 .27 .78 .75 .76 8.2 
986 1.21 1.13 1.25 1.20 9.1 17.3 
20 800 .67 .67 .61 .65 11.8 
X771 1.34 1.27 1.42 1.34 6.4 18.2 
21 457 1/20 .70 .67 .72 .70 145.0 
632 1/20 .52 .51 .53 .52 116.0 261.0 
Average daily excretion 15.7 mgm. Average daily excretion 
per 10 st. body weight 14.6 mgm. One day to become saturated. 
Nov. 
.65 .64 .60 
.66 .67 .65 
.50 .52 .52 
.88 .80 .83 
.96 1.06 .92 
1.85 1.93 1.85 
.62 .60 .61 
.98 .92 .98 
Aver-- As cor - 
age bic: ac. 
Titra- excretn 
tion per day Total 
mgm 
.63 6.1 
.66 10.4 16.5 
.51 9.8 
.84 6.7 16.5 
.98 9.0 
1.89 2.3 11.3 
.61 5.0 
.96 4.8 9.8 
14 552 1.06 
255 1.52 
15 628 .54 
624 1.18 
16 934 .54 
102g 2.13 
17 800 1.51 
18 257 1/2 .64 
586 1.84 
19 371 1/2 .98 
429 .60 
20 629 1.04 
X586 .52 
21 486 1.31 
286 1 -60 .61 
22 286 7, 60 .85 

















18.5 mgm. Average daily excretion 
per 10 stone body weight 17.2 mgm. Two days to become saturated. 
1.05 6.9 
1.50 16.0 22.9 
.55 13.3 
1.13 5.2 18.5 
.54 19.1 
2.15 5.4 24.5 
1.52 5.8 
.65 4.4 
1.86 6.0 10.4 
.97 8.4 
.59 8.1 16.5 
1.05 6.6 
.52 124.0 
1.31 41.0 Z65.0 
.61 282.0 
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7.1.37 -- 27.2.37. 1.7.37. onwards. 
Pleurisy 1 year ago. Cough sonie time before 
that. ass- Cavitation L. side. L. A.P.T. 
with clear effusion. 
B. '.R. 14. 
Weight 10 st. 11 -lbs. Dose of ascorbic acid 700 mgm. Diet ++ 
Amount Dilu- 
ur ine tion 
per 12 of Titration 










850 .5cc .91 .92 .92 
500 " 1.30 1.25 1.25 
1025 1.26 1.26 1.27 
1387 1 cc .84 .84 .88 
575 1/3 .5cc .92 .91 .94 
775 1/5" .66 .63 .60 
600 1/3" .77 .77 .76 
740 1/3 . 5cc1.18 1.21 1.13 
800 .5cc 1.20 1.01 .99 
860 1cc 1.22 1.18 1.20 
520 " .91 .91 .89 
348 .5cc 1.77 1.81 1.82 
Aver- Ascor- 
age bic ac. 
Titra- excretn 
tion per day Total 
mgm 
.92 5.1 
1.27 2.5 7.6 
1.26 4.1 
.85 16.3 20.4 
.92 9.8 
.63 34.0 43.8 
.77 12.9 
1.17 21.1 34.0 
1.07 4.5 
1.20 8.0 12.5 
.90 6.5 
1.80 1.2 7.7 
600 lcc 1.49 1.50 1.52 1.50 4.3 
998 .5cc .93 .96 .95 .95 2.9 7.2 
28 600 " .94 .91 .96 .93 6.1 
X 712 1/20 .60 .57 .57 .58 260.0 
29 826 1/25 1.27 1.30 1.31 1.29 120.0 380.0 
Average daily excretion 19.5 mgm. Average daily excretion 
per 10 stone body weight 17.3 mgm. Days taken to become 
saturated - 1. 
Sept. 
22 257 .76 .75 .78 .76 14.3 
757 1.73 1.77 1.77 1.75 4.8 19.1 
23 686 1.29 1.28 1.30 1.29 5.8 
571 1.22 1.27 1.26 1.25 5.2 11.0 
24 914 1.31 1.34 1.30 1.32 7.7 
686 1.64 1.64 1.68 1.65 4.5 12.2 
25 514 .92 .89 .91 .91 6.2 
457 .80 .75 .78 .78 6.5 12.7 
26 914 .84 .85 .83 .84 11.6 
286 .83 .83 .82 .83 3.8 15.4 
27 629 .77 .77 .77 .77 9.1 
629 .74 .77 .78 .76 9.3 18.4 
28 686 1.02 .96 .98 1.08 7.1 
400 .78 .79 .78 .78 5.7 12.8 
29 857 .82 .80 .84 .82 11.6 
H571 1 /10 .88 .87 .89 .88 36.0 
30 457 1/5 1.67 1.63 1.64 1.65 15.0 51.0 
686 1 /10 .50 .50 .52 .51 149.0 
Octl 771 1/20 .69 .65 .68 .67 256.0 405.0 
Average daily excretion 14.3 rngm. Average daily excretion 














18.2.37. onwards. TB*2 . No sputum now. 
Extensive disease tY roughout L. lung with 
cavitation. Si. infiltration rt. 
Artificial pneumothorax 4.3.37. Fair 
collapse. B.S.R. 6. 
d eight 8st. 5lbs, Dose of ascorbic acid 550.mgm. Diet ++ 
Amount Dilu- Aver- Ascor- 
urine ti on age bic ac. 
per 12 of Titration Titra- excretn 




















per 10 stone 
urated. 





















2.00 2.07 2.03 4.3 
.94 .95 .95 5.1 9.4 
1.03 1.09 1.07 0.1 
1.47 1.46 1.44 2.5 5.6 
1.00 1.03 1.01 4.2 
1.63 1.69 1.68 3.2 7.4 
.77 .76 .78 4.8 
1.42 1.41 1.40 4.4 9.2 
.64 .67 .65 13,7 
2.21 2.22 2,22 2.5 16.2 
1.09 1.08 1.09 2.1 
1.78 1.76 1.77 4.5 6.6 
.67 .68 .67 5.0 
1.68 1.70 1.69 15.3 
1.23 1.22 1.23 625.0 
1.30 1.33 1 .30 51.0 676.0 
8.9 mgm. Average daily excretion 
10.7 mgm. Two days to become sat- 
19 200 1.00 .97 1.00 .99 2.0 
1068 7.50 7.50 7.10 7.40 166 3 .6 
20 472 .50 .50 .50 .50 10.5 
972 5.85 5.80 5.80 5 .82 1.9 12.4 
21 472 .61 .64 .64 .63 8.1 
656 2.01 1.99 2.00 2.00 3.6 11.7 
22 200 .55 .55 .54 .55 4.1 
200 1/2 .90 .92 .91 .91 4.8 8.9 
23 900 .85 .85 .86 .85 11.8 
Nil 11.8 
24 200 .73 .75 .76 .75 2,9 
1100 1.65 1.70 1.72 1.69 7.3 10.2 
25 200 1.20 1.22 1.21 1.21 1.8 
954 1/4 .61 .59 .58 .59 61.6 
26 400 1/20 1.09 1.10 1.07 1.09 81.6 143.2 
1220 1/20 1.49 1.53 1.51 1.51 180.0 
27 920 1 /10 .51 .52 .53 .52 195.0 375.0 
Average daily excretion 9.7 mgm. Average daily excretion 











Admitted 30.5.38. Cough 5 months. Haemoptysis 
gv 21.3.38. Sputum- -Nil now. Infiltration and 
cavitation right upper lobe. Infiltn. mid zone. 
Artificial pneumothorax induced 5.7.38. Good 
collapse. Absolute rest. Afebrile. No enteritis. 
B.S.R. 24. 


















per day Total 
mgm Oct. c .c. 
13 700 .56 .60 .57 .58 13.5 
980 1.89 1.92 1.93 1.90 5.2 18.7 
14 936 .76 .78 .75 .76 13.8 
820 1.07 1.09 1.09 1.08 4.3 18.1 
15 360 .53 .53 .52 .53 7.6 
400 1.02 1.03 1.04 1.03 1.9 9.5 
16 500 .98 .96 .95 .96 5.9 
940 1.31 1.34 1.31 1.32 7.9 13.8 
17 320 .64 .65 .62 .64 5.6 
372 1.08 1.14 1.12 1.11 3.7 9.3 
18 172 .62 .65 .64 ..64 3.0 
320 1.5U 1.57 1.51 1.52 6.0 9.0 
19 412 1.12 1.14 1.10 1.12 4.1 
H540 1.60 1.62 1.62 1.61 3.7 
20 460 1.07 1.02 1.05 1 .05 24.5 28.2 
Nil 
21 200 1/20 .98 .98 .99 .98 44.0 44.0 
340 1/50 .84 .84 .84 .84 275.0 
22 480 1/20 .90 .89 .90 .89 119.0 394.0 
Average daily excretion 12.6 mgm. Average daily excretion 
per 10 stone body weight 15.7 mgm. Days to become satu- 
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Admitted 13.9.37. with history of cough, loss 
of weight etc., for two years. Photograph 
showed complete blood spread through right 
side with soft walled apical vomica. Left 
clean. Right'artificia.l pneumothorax 6.10.37. 
Fair collapse, cavity remains. Spread to left 
mid zone 9.4.38. which remains. Course of 
cadium in May onwards. Afebrile. TBt-2. 
Sputum iss -gi positive. B.S.R. 15. 
Height 9st. 31bs. Dose of ascorbic acid 750 mgm. Diet ++ 
Amount Dilu- 
urine tion 
per 12 of 




age bic ac. 
Titration Titra- excretn 























































































































































Average daily excretion 7.4 mgm; Average daily excretion 
per 10 stone body weight 8.0 mgm. Days to become satu- 















Pleurisy 1928. 11.7.38. 1934 treatment for 
small gastric ulcer. Indigestion troublesome. 
Thin. weight low for height. General condition 
poor. No sputum. hfebrile. Absolute rest. TBt3 
Bilateral fibroid phthisis. Larynx badly 
ulcerated. B.S.R. 7. 
'weight 9st. 9lbs. Dose of ascorbic acid 650 mgm. Diet sli -htly 
deficient. 
Amount Dilu- Aver- Ascor- 
urine tion age bic ac. 
per 12 of .Titration Titra- excretn 
1938. hours urine Readings tion per day Total 
Jly. c.c. mgm 
29 752 .5cc 1.03 1.00 .97 1.00 4.2 
400 " .80 .79 .81 .80 5.5 9.7 
30 792 " 1.40 1.43 1.43 1.42 3.0 
1772 " 3.20 3.13 3.30 3.21 3.1 6.1 
31 400 " 1.36 1.33 1.32 1.34 1.7 
1200 " 2.20 2.25 2.24 2.23 3.0 4.7 
Augl 824 " 2.81 2.85 2.80 2.82 1.2 
1680 " 2.13 2.09 2.16 2.13 4.4 5.6 
2 1628 `i 3.00 3.06 2.96 3.01 2.5 
1000 " 3.20 3.40 3.60 3.40 1.65 4.1 
3 400 " 2.83 3.10 3.30 3.08 .7 
532 ' 3.70 3.80 4.10 3.87 .7 1.4 
4 1220 lcc 2.60 2.70 2.70 2.67 5.0 
31000 .5cc 1.45 1.51 1.38 1.45 4.6 
5 860 " .57 .57 .59 .58 8.5 13.1 
732 " 3.68 3.71 3.80 3.73 1.0 
6 760 " .76 .77 .79 .77 5.5 6.5 
572 
If 
.58 .57 .57 .57 5.6 
7 400 
u 
1.84 1.81 1.85 1.83 1.3 6.9 
772 1/2 1.82 1.80 1.83 1.82 96,0 
8 400 1/20 1.44 1.47 1.47 1.46 57.0 153.0 
1600 1/20 1.46 1.50 1.50 1.48 246 .0 
9 1052 1 /10 1.02 .99 1.01 1.00 106.0 352,0 
Average daily excretion 5.5 mgm. Average daily excretion 













3.45 3.40 3.49 
5.3U 5.60 5.48 
3.53 3.62 3.48 
4.10 3.90 3.85 
2.55 2.55 2.52 
26.4 2.85 2.69 
1.82 1.93 1.86 
3.52 3.51 3.49 
1.68 1.65 1.65 
























Summary of 20.6.29 -- 10.9.36. 4.10.37. Cough 2 years. 
history: gi+ sputum. Bilateral fibrotic disease. 
B.S.R. 12.5 
eight 9st. 21bs. Dose of ascorbic acid 650 mgm. Diet+ 
Amount Dilu- ever- Ascor- 
urine tion age bic ac. 
per 12 of Titration Titra- excrtn 
1938. hours urine Readings tion per day Total 
. c.c. mgm 
21 600 .94 .92 .95 .94 7.0 
22 486 .62 .63 .61 .62 8.8 
22 686 .78 .78 .81 .79 9.6 18.4 
23 829 .64 .65 .65 .65 14.3 
914 .97 .99 .98 .98 10.4 24.7 
24 343 .76 .75 .75 .75 5.1 
571 .73 .73 .74 .73 8.7 13.8 
25 914 .75 .75 .77 .76 13.8 
800 1/2 .64 .60 .66 .63 29.8 43.4 
26 1371 .56 .55 .53 .55 27.9 
857 1/2 .96 .94 .98 .96 19.8 47.7 
28 385 .64 .63 .62 .63 6.9 
1143 .97 .91 .94 .94 13.5 20.4 
29 1057 .75 .74 .79 .76 15.5 
H1143 1 /1° .96 .98 .96 .97 149.0 
629 1/20 .96 .96 .99 .97 144.0 293.0 
Average daily excretion 28.2 mgm. Average daily excretion 
per 10 stone body weight 30.1 mgm. One day to become sat- 
urated. 
Sept. 
22 686 1.79 1.83 1.84 1.82 4.2 
514 .82 .88 .84 .84 6.5 10.7 
23 686 1.39 1.46 1.48 1.44 5.3 
400 .87 .90 .91 .89 5.0 10.3 
24 1600 1.68 1.60 1.62 1.63 10.7 
Wasted 
25 1200 1.35 1.36 1.31 1.34 10.0 
1200 1.06 1.12 1.08 1.09 3.2 13.2 
26 320 1.28 1.29 1.30 1.29 2.8 
1720 1.00 1.00 .99 1.00 19.1 21.9 
27 880 .80 .81 .82 .81 12.0 
800 1.23 1.27 1.26 1.25 7.1 19.1 
28 360 .92 .96 .94 .94 4.2 
760 .56 .52 .53 .54 15.5 19.7 
29 1600 1.93 1.93 1.98 1.95 9.2 
# 505 1/20 1.01 1.02 1.00 1.01 111.0 
30 90 1/2 2.10 2.09 2.08 2.09 9.6 129.8 
250 1/40 .59 .58 .58 .58 176.4 
31 228 1/40 .79 .79 .78 .79 128.0 304.4 
Average daily excretion 15.9 mgm. Average daily excretion 
per 10 stone 
urated. 
body weight 17.3 mgm. Two days to become sat- 

OICallaah.an. 
Summary of 3.6.20.- 14.4.21. 27.6.29. 
history: History of cough etc. from 1916. 3i+ sputum 
Bilateral fibrotic disease. B.S.R. 25.5 
ú eight 8st llbs. Dose of ascorbic acid 550 mgm. Diet - ay. 
Amount Dilu- 
urine tion 
per 12 of Titration 
1938. hours urine Readings 
Áúg: c.c. 
Aver- Ascor- 
age bic ac. 
Titra- excretn 
tion per day Total 
mgm 
14 828 1.46 1.46 1.48 1.47 6.4 
229 1.12 1.16 1.15 1.14 2.2 8.6 
15 686 1.98 2.01 2.00 2.00 3.8 
343 1.03 1.02 1.02 1.02 3.7 7.5 
16 714 2.32 2.40 2.42 2.38 3.4 
629 1.70 1.75 1.73 1.73 4.1 7.5 
17 571 1.97 1.94 2.00 1.97 3.1 
457 .84 .86 .86 .85 5.9 9.0 
18 829 1.41 1.45 1.46 1.44 6.4 
428 1.11 1.12 1.13 1.12 4.3 10.7 
19 657 3.20 3.27 3.25 3.24 2 .2 
257 1.75 1.75 1.77 1.76 1.6 3.8 
20 Lost 
21 114 2.04 2.04 2.02 2.03 .6 
X 571 1/20 .59 .59 .61 .60 212 . 0 
22 800 1/10 1.47 1.50 1.48 1.48 68.0 280.0 
Average daily excretion 7.9 mgm. Average daily excretion 
per 10 stone body weight 9.9 mgm. One day to become sat- 
urated. 
GZ.., vt.ìcy : . ..+ . ' 











Summary of Patient from 24.9.34 -- 9.2.35. 11.4.38 -- 12.9.38. 
history: TB*2. Haemoptysis Aug. 1934. Slight cough. Gain- 
ing weight. afebrile. Fibrotic apical disease - 
no cavities. BSR. 8. 




















per day Total 
Aug. C.C. mgm 
8 628 1.16 1.18 1.19 1.18 2.8 
628 .89 .93 .91 .91 7.7 10.5 
9 742 .83 .80 .82 .82 10.2 
510 .90 .93 .91 .91 6.2 16.4 
10 857 .62 .62 .61 .61 15.3 
942 .79 .80 .83 .81 11.3 26.6 
11 457 .91 .89 .91 .90 5.6 
686 2.15 2,00 2.00 2.05 3.7 9.3 
12 171 1.17 1.15 1.19 1.17 1.6 
1028 1.49 1.52 1.53 1.52 7.1 8.7 













15 486 1/3 .91 .87 .88 .89 18.3 
X4105 7 1/5 .48 .51 .50 .49 118.0 
16 571 1/20 .72 .74 .71 .73 175.6 293.6 
Average daily excretion 17 mgm. Average daily excretion 
per 10 stone body weight 15 mgm. One day to become sat- 
urated 
61-"1- '6'441 / a 















26.9.32.-- 7.11.32. 28.10.37. -- 20.12. 37. 
3.2.38 onwards. Cough one year. Loss of weight. 
No sputum. Chronic bronchitis, with infiltrated 
apices. TB- B.S.R. 8.5 





















per day Total 
c.c. mgm 
15 640 1.65 1.68 1.63 1.66 4.3 
300 1.58 1.62 1.61 1.60 2.1 6.4 
16 200 1/2 .86 .84 .86 .85 5 .0 
980 1.26 1.27 1.26 1.26 8.7 13.7 
17 400 .54 .54 .55 .54 8.0 
860 1.78 1.74 1.77 1.76 5.6 13.6 
18 760 1.49 1.46 1.48 1.48 5.7 
912 1.50 1.51 1.55 1.52 6.6 12.3 
19 732 .98 .99 .98 .98 8.4 
440 2.30 2.37 2.34 2.33 2.0 10.4 
20 1320 1.34 1.36 1.32 1.34 11.0 
640 2.81 2.85 2.87 2.84 2.8 13.8 
21 360 .90 .88 .90 .89 4.5 
600 2.21 2.27 2.33 2.27 2.9 7.4 
23 200 .91 ,91 .89 .90 2.4 
3 880 1/10 .81 .80 .81 .80 119.0 
24 200 1 /1° 1.02 1.01 1.02 1.02 22.0 141.0 
852 1/20 .65 .63 .63 .64 296.0 
25 1/20 1.84 1.80 1.78 1.81 83.0 379.0 
Average daily excretion 10.9 mgm. Average daily excretion 














18.2 .37. - 18.4.37. 23.12 .37 onwards. 
3 years cough etc. TB+2. 
Very extensive disease. B.S.R. 17.2 
Weight 8st. 9lbs. Dose of ascorbic acid 6u0 mgm. Diet+ 
Amount Dilu- 
urine tion 
per 12 of 










per day Total 
Aug. c.c. mgm 
22 714 .54 .52 .54 .53 14.7 
486 .95 .95 .93 .94 5.7 20.4 
23 343 .53 .54 .52 .53 7.3 
800 1.02 1.00 .97 .99 6.7 14.0 
24 457 .61 .63 .64 .63 8.2 
514 .77 .75 .76 .76 7.5 15.7 
25 600 .88 .90 .88 .89 7.5 
857 .65 .68 .70 .68 14.0 21.5 
26 371 1.04 1.06 1.06 1.05 3.9 
628 .95 .97 .95 .96 7.3 11.2 
28 343 1/2 .88 .92 .92 .91 8.4 
971 .70 .67 .69 .69 13.7 22.1 
29 514 .75 .74 .79 .76 7.5 
X229 1/3 1.24 1.23 1.26 1.24 6.3 
30 514 1/5 1.50 1.49 1.49 1.49 23.0 29.3 
514 1/20 .98 1.00 1.00 .99 128.0 
31 343 1/50 1.66 1.70 1.74 1.70 112.0 2440.0 
Average daily excretion 17.5 mg;m. Average daily excretion 
per 10 stone body weight 20 mgm. Days to become saturated 2. 
Sept. 
23 286 .59 .62 .62 .61 5.1 
400 .92 .91 .94 .92 4.8 9.9 
24 686 1.03 1.03 1.02 1.03 7.5 
100 1.21 1.23 1.22 1.22 9.0 16.5 
25 880 .84 .85 .80 .83 11.7 
100 .56 .54 .54 .55 2.0 13.7 
26 Nil 
1120 .97 .98 .97 .98 14.3 14.3 
27 380 1.20 1.20 1.24 1.21 3.5 
1320 1.11 1.16 1.17 1.14 13.2 16.7 
28 1040 .81 .80 .82 .81 14.2 
1100 1/2 .82 .82 .86 .84 26.2 40.4 
29 400 .78 .77 .74 .76 5.9 X 
300 1/20 .78 .76 .77 .77 86.0 91.9 
30 85 1 /10 2.00 1.97 1.95 1.97 4.8 
245 1/20 1.90 1.92 1.93 1.92 288.0 2 92 .8 
Average daily excretion 17.2 mgm. Average daily excretion 
per 10 stone body weight 19.7 mgm. Days to become saturated 2. 

Summary of Cough, loss of weight, since Jan. 1931. 
history: Extensive bilateral fibrotic disease. 
TBf2 B.S.R . 24. 
üeight 9st 2lbs. Dose of ascorbic acid 650 mgm. Diet average. 
1938. 
Au g . 
Amount Dilu- 
urine tion 











per day Total 
mgm c.c. 
8 1485 1.12 1.16 1.14 1.14 7.2 
714 1.79 1.82 1.80 1.80 4.5 11.7 
9 457 .83 .86 .82 .84 6.1 
742 .88 .92 .94 .91 9.0 15.1 
10 685 .93 .91 .95 .93 8.1 
942 1.40 1.41 1.39 1.40 7.4 15.5 
11 571 1.29 1.31 1.31 1.30 4.1 
400 1.46 1.47 1.49 1.47 3.1 7.2 
12 571 1.33 1.34 1.36 1.34 4.7 
1085 1.16 1.13 1.18 1.16 10.4 15.1 
13 On pass 
14 571 .84 .80 .84 .83 7.7 
1028 .52 .48 .51 .50 22.8 30.6 
15 629 1.07 1.06 1.06 1.06 6.5 
3 486 1/3 1.38 1.44 1.41 1.41 17_ .7 
16 629 1/2 1.07 1.11 1.12 1.10 12.7 24.4 
714 1/20 1.32 1.;53 1.30 1.32 121.0 
17 457 1/20 1.11 1.18 1.12 1.14 89.4 210.4 
Went out against advice. 
Average daily excretion 15.5 mgm. Average daily excretion 




Summary of 3 years history. Left artifical pneumothorax, 
history: with effective collapse with cavity being shut 
down. Ready for discharge. B.S.R. 8. 
Wight: 8st. llbs. Dose of ascorbic acid 550 mgm. Diet: 
little+ 
Amount Dilu- Aver- Ascor- 
urine tion age bic ac. 
per 12 of Titration Titra- excretn 
1938. hours urine Readings tion per day Total 
Oct. c.c. mgm 
16 400 1/5 1.27 1.26 1.27 1.27 
260 1/2 .84 .84 .84 .84 
17 1000 .59 .55 .54 .56 
420 1/2 .67 .66 .67 .67 
18 500 .65 .68 .66 .66 
816 1.55 1.55 1.50 1.53 
19 200 .78 .78 .79 .78 
520 .95 .93 .98 .95 
20 520 .58 .56 .56 .57 
680 .63 .63 .62 .63 
21 400 .80 .82 .78 .80 
360 1.50 1.52 1.53 1.52 
23 240 .53 .53 .54 .53 
400X 1/5 .97 .98 .98 .97 
24 480 1/5 .96 .98 .94 .96 
640 1/40 .65 .65 .66 .65 


















Average daily excretion 16.7 mgm. Average daily excretion 




Summary of. 29.7.37. 4 months history. Tuberculous larynx 
history: on admission. Bilateral fibrotic disease. §1.1+ 
Large cavity left side. B.S.R. 26. 



















per day Total 
Aug. c.c. mgm 
24 314 .56 .55 .57 .56 6.1 
1143 1.13 1.14 1.13 1.13 11.1 17.2 
25 1029 .78 .76 .79 .78 13.3 
800 1.17 1.18 1.14 1.16 7.6 20.9 
26 971 1.15 1.14 1.12 1.14 9.5 
1285 1.87 1.91 1.91 1.90 7.6 17.1 
29 571 .59 .58 .54 .57 11.2 
1343 1.34 1.36 1.35 1.35 11.3 22.5 
30 1143 1.01 1.01 1.02 1.01 12.5 
1200 .95 .97 .96 .96 13.9 26.4 
31 1029 .78 .80 .83 .80 14.3 
X 314 1/5 .68 .68 .66 .67 25.9 40.2 
Sept1 1029 1/5 .61 .62 .62 .62 94.5 120.4 
2nd dos e13 43 1/5 .72 .72 .72 .72 2 08 .0 
2 943 1/3 .53 .53 .51 .52 60.0 268.0 
Average daily excretion 22.6 mgm. Average daily excretion 
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Summary of 7.10.37. 3 years history left pleurisy. 




9st. 8lbs. Dose of ascorbic acid 
Amount Lilu- 
urine tion 
per 12 of Titration 
hours urine Readings 
650 man. Diet 
average. 
Aver- Ascor- 
age bic ac. 
Titra- excretn 
tion per day Total 
mgm c.c. 
7 371 .55 .53 .55 .54 7.6 
628 1.43 1.43 1.40 1.42 4.8 12.4 
8 400 1.49 1.52 1.52 1.51 S.9 
628 1.03 1.08 1.05 1.05 3.3 6.2 
9 371 .85 .88 .85 .86 4.9 
371 .87 .87 .89 .88 4.8 9.7 
10 1229 .94 .97 .92 .94 14.4 
800 .82 .79 .80 .81 9.6 14.0 
11 657 1.61 1.65 1.65 1.64 4.4 
800 1.63 1.63 1.64 1.63 5.3 9.7 
12 1143 1.98 1.99 1.97 1.98 6.3 
800 1.32 1.30 1.36 1.34 6.6 12.9 
13 On pass 
14 229 1/2 1.02 M.98 .98 .99 5.8 
X600 .68 .64 .67 .66 10.0 
15 829 .89 .93 .93 .91 10.0 20.0 
571 .69 .71 .73 .71 8.9 
16 886 1.20 1.24 1.22 1.22 8.1 16.0 
1371 1/20 1.28 1.25 1.26 1.26 242.6 
17 1057 1/5 1.12 1.12 1.17 1.13 51.5 294.1 
943 .63 .60 .62 .62 17.3 
Average 'daily excretion 10.9 ,;gm. Average daily excretion 
per 10 stone body weight 11.4 mgm. Days to become satu- 
rated - 3. 

Violstencroft. 
Summary of 5.7.37. onwards. 2 years history. z i-f- 
history: Bilateral fibrolic disease with cavitation. 
B.S.R. 21. 
Veight about 11 st. Dose of ascorbic acid 750 mgm. Diet - 
TT o fruit. 
Amount Dilu- Aver- Ascor- 
urine tion age bic ac. 
per 12 of Titration Titra- excretn 
1938. hours urine Readings tion per day Total 
c.c. Aug. 
8 571 .60 .64 .62 .62 
1142 2.37 2.41 2.38 2 .38 
9 971 .5cc 1.73 1.71 1.72 1.72 
400 1.19 1.19 1.21 1.19 
10 714 1.27 1.30 1.30 1.29 
1028 1.78 1.82 1.77 1.79 
11 400 .84 .84 .87 .85 
1143 1.22 1.21 1.20 1.21 
12 457 .5cc 1.27 1.26 1.20 1.24 
1600 3.30 3.13 3.15 3.19 
13 457 1.28 1.25 1.28 1.27 
914 1.69 1.73 1.75 1.72 
14 On pass 
15 H 914 1/2 .92 .92 .95 .93 
1028 .90 .88 .88 .89 
714 1/3 .72 .70 .70 .71 
16 514 1/20 1.93 1.96 1.94 1.94 
686 1/20 1.03 .99 .97 1.00 





























Average daily excretion 11.5 mgm. Average daily excretion 













Grau pman . 
Summary of 
history: 
In hospital 5.7.34-25.10.34. 2.12.35-4.6.36. 
3.10.36 -3.6.38. Cough past year. Bilateral 
fibrotic disease with cavitation. give 
General condition' rather poor. Up 12 hrs. 
B.S.R. 11. 








e of ascorbic acid 650 mgm. Diet - 
Deficient 
Aver- Ascor- 
age bic ac. 
Titration Titra- excretn 
Readings pion per day Total 
6 1120 .5cc 2.15 2.10 2.00 2.08 
400 " 4.20 4.20 4.40 4.27 
7 216 1.38 1.34 1.33 1.35 
820 2.19 2.13 2.17 2 .16 
8 424 1.82 1.85 1.86 1.84 
272 .5cc 1.95 1.95 1.05 1.65 
9 400 " 1.08 1.05 1.06 1.06 
1312 1.28 1.28 1.26 1.27 
10 208 .5cc 1.36 1.39 1.38 1.38 
472 2.20 1.96 2.09 1.99 
11 128 1.10 1.12 1.09 1.10 
400 6.23 6.20 6.40 6.28 
12 320 .6cc 2.10 2.10 2.20 2.13 
Not saved 
13 On pass 
14 200 1.61 1.64 1.58 1.61 
X 272 1.04 1.01 1.03 1.04 
15 264 3.13 3.16 3.18 3.16 
244 4.03 4.00 4.09 4.04 
16 572 3.71 3.68 3.76 3.72 
1172 .57 .54 .57 .56 
17 500 2.40 2.45 2.48 2.44 
640 1 /10 .82 .84 .82 .83 
18 180 1 /10 .68 .67 .67 .67 
1000 2.67 2.65 2.60 2.64 
19 280 1.40 1.41 1.40 1.40 
732 1 /10 1.63 1.63 1.65 1.63 
20 300 .52 .54 .52 .53 
572 .52 .54 .52 .53 
21 660 1/5 .76 .96 1.00 .99 
800 1/20 .83 .82 .81 .82 













































Average daily excretion 5.4 mgm. Average daily excretion per 






In hospital 5.7.34-25.10.34.2.12.35-4.6.36. 
3.10.36- 3.6.38. Cough past year. Bilateral 
fibrolic disease with cavitation. giv 
General condition rather poor. Up 12 hrs. 
B.S.R.11. 



















per day Total 
Oct. c.c. mgm 
9 771 1.41 1.43 1.38 1.41 6.0 
1571 2 .86 2 .93 2.81 2.87 6.1 12.1 
10 800 1.18 1.16 1.19 1.18 7.6 
314 1.74 1.76 1.78 1.76 1.9 9.5 
12 1086 1.27 1.26 1.22 1.25 9.7 
1924 3.74 3.69 3.67 3.77 5.7 15.4 
13 1057 1.28 1.28 1.29 1.28 9.2 
1086 2.75 2.79 2 .80 2.78 4.3 13.5 
14 1057 1.24 1.26 1.19 1.23 9.5 
1371 2.13 2.11 2.07 2.10 7.1 16.6' 
16 800 1.06 1.09 1.05 1.07 8.3 
1599 2.47 2 .50 2.49 2.48 7.4 15.7 
17 1256 .92 92 .91 .92 15.2 
1148 1.54 1.50 1.58 1.54 8.3 23.5 
18 914 1.14 1.15 1.12 1.14 8.9 
X 385 1/5 .63 .64 .62 .63 33.5 
19 1200 1/20 1.63 1.65 1.61 1.63 89.0 122.5 
685 1/20 .73 .74 .73 .73 208.0 
20 857 1/20 .83 .85 .81 .83 228.0 436.0 
Average daily excretion 11.0 Average daily excretion per 
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